Factor VII-activating protease in patients with acute deep venous thrombosis

Thrombosis Research

Volumn 122, Issue 6, 2008, Pages 848-853

  Sidelmann, Johannes J ^a,b   Vitzthum, Frank ^c   Funding, Eva ^b   Münster, Anna Marie B ^b   Gram, Jørgen ^a,b   Jespersen, Jørgen ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Hospital of South West Denmark ^*  (Denmark)

^c SIEMENS AG   (Germany)

Author keywords

C reactive protein; Deep venous thrombosis; Factor VII activating protease; Inflammation; Marburg I polymorphism; Prothrombin fragment 1 + 2

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; PROTEINASE; UROKINASE RECEPTOR;

ARTICLE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; PHENOTYPE; PRIORITY JOURNAL;

ACUTE DISEASE; C-REACTIVE PROTEIN; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; SERINE ENDOPEPTIDASES; VENOUS THROMBOSIS;

EID: 52049083234     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.02.002     Document Type: Article

References (29)

1. Choi-Miura N.H., Tobe T., Sumiya J., Nakano Y., Sano Y., Mazda T., et al. Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. J Biochem (Tokyo) 119 (1996) 1157-1165
2. Altincicek B., Shibamiya A., Trusheim H., Tzima E., Niepmann M., Linder D., et al. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding. Biochem J 394 (2006) 687-692
3. Kannemeier C., Al Fakhri N., Preissner K.T., and Kanse S.M. Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells. FASEB J 18 (2004) 728-730
4. Shibamiya A., Muhl L., Tannert-Otto S., Preissner K.T., and Kanse S.M. Nucleic acids potentiate factor VII activating protease (FSAP)-mediated cleavage of platelet derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation. Biochem J 404 (2007) 45-50
5. Etscheid M., Beer N., and Dodt J. The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. Cell Signal 17 (2005) 1486-1494
6. Sedding D., Daniel J.M., Muhl L., Hersemeyer K., Brunsch H., Kemkes-Matthes B., et al. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. J Exp Med 203 (2006) 2801-2807
7. Romisch J., Feussner A., Vermohlen S., and Stohr H.A. A protease isolated from human plasma activating factor VII independent of tissue factor. Blood Coagul Fibrinolysis 10 (1999) 471-479
8. Romisch J., Vermohlen S., Feussner A., and Stohr H. The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 29 (1999) 292-299
9. Roemisch J., Feussner A., Nerlich C., Stoehr H.A., and Weimer T. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP). Blood Coagul Fibrinolysis 13 (2002) 433-441
10. Willeit J., Kiechl S., Weimer T., Mair A., Santer P., Wiedermann C.J., et al. Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis. Circulation 107 (2003) 667-670
11. Kanse S.M., Linn T., Taioli E., Sürücü O., Matz R., Henning S., et al. Factor VII activating protease inhibits angiogenesis in vivo. 50 Jahrestagung der gesellschaft für Thrombose-und Hämostaseforschung e V (2006)
12. Etscheid M., Beer N., Fink E., Seitz R., and Johannes D. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin. Biol Chem 383 (2002) 1633-1643
13. Ireland H., Miller G.J., Webb K.E., Cooper J.A., and Humphries S.E. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. Thromb Haemost 92 (2004) 986-992
14. Hoppe B., Dorner T., Kiesewetter H., and Salama A. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 95 (2006) 907-908
15. Franchi F., Martinelli I., Biguzzi E., Bucciarelli P., and Mannucci P.M. Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism. Blood 107 (2006) 1731
16. Gulesserian T., Hron G., Endler G., Eichinger S., Wagner O., and Kyrle P.A. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 95 (2006) 65-67
17. van Minkelen R., de Visser M.C., Vos H.L., Bertina R.M., and Rosendaal F.R. The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis. Blood 105 (2005) 4898
18. Sidelmann J.J., Sjoland J.A., Gram J., Bertelsen V., Mourits-Andersen T., Munster H., et al. Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest 67 (2007) 270-279
19. Rabinov K., and Paulin S. Abrams angiography. Vascular and interventional radiology. Dynamics of venous contrast filling in the normal venogram. In: Abrams H.L. (Ed) (1983), Little, Brown and Co., Boston 1884-1887
20. Romisch J., Feussner A., and Stohr H.A. Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects. Blood Coagul Fibrinolysis 12 (2001) 375-383
21. Kannemeier C., Feussner A., Stohr H.A., Weisse J., Preissner K.T., and Romisch J. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. Eur J Biochem 268 (2001) 3789-3796
22. Romisch J. Factor VII activating protease (FSAP): a novel protease in hemostasis. Biol Chem 383 (2002) 1119-1124
23. Bladbjerg E.M., Gram J., Jespersen J., and de Maat M.P. Internal quality control of PCR-based genotyping methods in research studies and patient diagnostics. Thromb Haemost 87 (2002) 812-816
24. Hoppe B., Tolou F., Radtke H., Kiesewetter H., Dorner T., and Salama A. Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. Blood 105 (2005) 1549-1551
25. Hoppe B., Tolou F., Dorner T., Kiesewetter H., and Salama A. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Thromb Haemost 96 (2006) 465-470
26. Gram J., Sidelmann J., and Jespersen J. Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis?. Thromb Haemost 74 (1995) 718-721
27. Isordia-Salas I., Pixley R.A., Sainz I.M., Martinez-Murillo C., and Colman R.W. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. Arch Med Res 36 (2005) 87-95
28. Fox E.A., and Kahn S.R. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 94 (2005) 362-365
29. Wygrecka M., Morty R.E., Markart P., Kanse S.M., Andreasen P.A., Wind T., et al. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute distress syndrome. J Biol Chem 282 (2007) 21671-21682